Vol 9, No 3 (2017)
Literature Highlights
| Alectinib (Alecensa) as First-line Option for ALK-positive Lung Cancer | Abstract PDF |
| M. Saeed Sheikh | 15 |
FDA Corner
| FDA Approval Brings First Gene Therapy to the United States | Abstract PDF |
| 17-18 |
| FDA Approves First Continuous Glucose Monitoring System for Adults Not Requiring Blood Sample Calibration | Abstract PDF |
| 18-19 |
| FDA Approves CAR-T Cell Therapy to Treat Adults With Certain Types of Large B-cell Lymphoma | Abstract PDF |
| 19-20 |
| FDA Approves First Once-Monthly Buprenorphine Injection, a Medication-assisted Treatment Option for Opioid Use Disorder | Abstract PDF |
| 20-21 |